幽门螺旋杆菌感染的诊治进展

路晓明

【期刊名称】《医药与保健》

【年(卷),期】2014(000)010

【摘要】Helicobacter pylori (H.pylori) affects nearly half of the world’s population,so it is one of the most frequent and persistent bacterial infections all over the world. H. pylori is associated with peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer.Various diagnostic methods exist to detect infection, and the choice of one method or another depends on several factors, such as accessibility,advantages and disadvantages of each method, cost, and the age of patients.The clinician need to decide whether treatment is necessity, according to the patient’s clinical condition.Cure rates with the standard triple therapy are acceptable,and quadruple therapies,sequential therapies, and concomitant therapies are effective and have been introduced as key alternatives to treat H. pylori infection. In this work, we review the main diagnostic methods used to identify H. pylori infection and to confirm eradication of infection. In addition, key factors related to treatment are reviewed.%近一半的世界人口感染幽门螺旋杆菌（H.pylori），幽门螺旋杆菌（HP）是世界上最常见且最持久的细菌感染之一。幽门螺旋杆菌感染与消化性溃疡病，胃黏膜相关淋巴组织淋巴瘤、胃癌的发生发展密切相关。目前诊断HP感染的检测方法有很多，检测方法的选